Trial
NCT01539174
Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated High- or High-Intermediate-Risk Diffuse Large B-Cell Lymphoma
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Fox Chase Cancer Center
Collaborators
Genentech, Inc.
Condition
Contiguous Stage II Adult Diffuse Large Cell Lymphoma
Intervention
rituximab
Why stopped
No Funding Source and Competing Trials
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-03-03